Inventor · disambiguated record
Yusuke Sasaki
Also filed as: SASAKI YUSUKE
15 granted patents·6 pending applications·253 citations·filing 2004–2024
91Inventor score
Files withTAKEDA PHARMACEUTICALS CO12KOWA CO5LSI MEDIENCE CORP1NISSAN CHEMICAL IND LTD1SLOAN KETTERING INST CANCER RES1
Top patents by PatentIndex Score
21 records- 0197US7776881B2Hyperlipemia therapeutic agentKOWA CO·Filed 2005·Granted Aug 17, 2010·103 cites·7 claims
- 0296US7022713B2Hyperlipemia therapeutic agentNISSAN CHEMICAL IND LTD·Filed 2004·Granted Apr 4, 2006·126 cites·2 claims
- 0389US11666594B2Antibody-drug conjugates comprising a cyclic dinucleotideTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jun 6, 2023·2 cites·19 claims
- 0488US9890145B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Feb 13, 2018·8 cites·10 claims
- 0583US10000488B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jun 19, 2018·3 cites·13 claims
- 0682US10472376B2Amide compoundTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Nov 12, 2019·5 cites·13 claims
- 0782US2025205270A1Antibody-drug conjugate precursors comprising a cyclic dinucleotideTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 0881US9321757B2Heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2014·Granted Apr 26, 2016·5 cites·13 claims
- 0980US12171777B2Methods of making a cyclic dinucleotideTAKEDA PHARMACEUTICALS CO·Filed 2023·Granted Dec 24, 2024·0 cites·20 claims
- 1076US11053262B2Heterocyclic amide compounds having RORyT inhibitory actionTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Jul 6, 2021·1 cites·22 claims
- 1174US2024325356A1Prophylactic and therapeutic drug for nonalcoholic fatty liver diseaseKOWA CO·Filed 2024·Application pending·0 cites
- 1273US11851449B2Heterocyclic amide compounds having an RORvt inhibitory actionTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Dec 26, 2023·0 cites·11 claims
- 1369US12042483B2Prophylactic and therapeutic drug for nonalcoholic fatty liver diseaseKOWA CO·Filed 2021·Granted Jul 23, 2024·0 cites·11 claims
- 1463US2024309016A1Macrocyclic heterocycle compounds and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 1562US2024217957A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1657US2020022960A1Prophylactic and therapeutic drug for nonalcoholic fatty liver diseaseKOWA CO·Filed 2018·Application pending·0 cites
- 1742US10774083B2Heterocyclic amide compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Sep 15, 2020·0 cites·5 claims
- 1841US12478616B2PI3K inhibitors and uses thereofSLOAN KETTERING INST CANCER RES·Filed 2019·Granted Nov 25, 2025·0 cites·25 claims
- 1941US10800754B2Heterocyclic amide compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Oct 13, 2020·0 cites·2 claims
- 2041US2008045567A1Therapeutic Agent for Hyperlipemia and Therapeutic Agent for DiabetesKOWA CO·Filed 2005·Application pending·0 cites
- 2132US10557848B2Polymer microparticle for carrying physiologically active substance and method for preparing sameLSI MEDIENCE CORP·Filed 2015·Granted Feb 11, 2020·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Yusuke Sasaki files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →